Stockbabie NewsFatherMarketNewsMarket Intelligence
Subscribe
MARKETS
Wire · Earnings
Earnings

Lifecore Biomedical Affirms FY2026 Sales Guidance of $120.000M-$125.000M vs $122.176M Est

Aug 5, 2026 · 07:06 AM ET· updated 2h ago

Lifecore Biomedical (NASDAQ:LFCR) affirms FY2026 sales outlook from $120.000 million-$125.000 million to $120.000 million-$125.000 million vs $122.176 million estimate.

Share
Why It Matters

Lifecore said their sales next year will be between $120M–$125M, which is pretty close to what Wall Street thought they'd make. This tells you the company feels confident about their plans, even if there's no big surprise either way.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
LFCR4.51
+0.16 (+3.70%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.